A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
https://news.vumc.org/2021/08/12/study-identifies-biomarker-for-breast-cancer-response-to-immunotherapy/
![news](/sites/default/files/drupalfiles/2023-02/VUMC-News_final_0.jpg)